Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2

BACKGROUND: Genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to emerge in 2020 and have been spreading globally during the coronavirus disease 2019 (COVID-19) pandemic. Despite the presence of different COVID-19 vaccines, the discovery of effective antiviral the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngwe Tun, Mya Myat, Sakura, Takaya, Sakurai, Yasuteru, Kurosaki, Yohei, Inaoka, Daniel Ken, Shioda, Norifumi, Yasuda, Jiro, Kita, Kiyoshi, Morita, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739347/
https://www.ncbi.nlm.nih.gov/pubmed/34991723
http://dx.doi.org/10.1186/s41182-021-00397-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739347/
https://www.ncbi.nlm.nih.gov/pubmed/34991723
http://dx.doi.org/10.1186/s41182-021-00397-x

Ejemplares similares